CUSIP: 65344D109
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,952,044
-
Share change
-
-1,865,423
-
Total reported value
-
$1,449,150
-
Price per share
-
$0.24
-
Number of holders
-
27
-
Value change
-
-$1,248,031
-
Number of buys
-
10
-
Number of sells
-
14
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2023
-
Previous quarter:
Q3 2022
Recent filing periods for CUSIP 65344D109:
Institutional Holders of NEXIMMUNE INC - COM (NEXI) as of Q4 2022
As of 31 Dec 2022,
NEXIMMUNE INC - COM (NEXI) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,952,044 shares.
The largest 10 holders included
Artal Group S.A., GOLDMAN SACHS GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., ALLEN OPERATIONS LLC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, EPIQ Capital Group, LLC, RENAISSANCE TECHNOLOGIES LLC, PNC Financial Services Group, Inc., and M28 Capital Management LP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.